# A Research Study Looking at Different Oral Formulations and the Effect of Food Intake on How the Medicine NNC0487-0111 Behaves in the Body of Participants Living With Overweight or Obesity

> **NCT06478563** · PHASE1 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 133 (actual)

## Conditions studied

- Obesity
- Overweight

## Interventions

- **DRUG:** NNC0487-0111 (formulation D)
- **DRUG:** NNC0487-0111 (formulation C)

## Key facts

- **NCT ID:** NCT06478563
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-27
- **Primary completion:** 2025-06-05
- **Final completion:** 2025-07-01
- **Target enrollment:** 133 (ACTUAL)
- **Last updated:** 2025-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06478563

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06478563, "A Research Study Looking at Different Oral Formulations and the Effect of Food Intake on How the Medicine NNC0487-0111 Behaves in the Body of Participants Living With Overweight or Obesity". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06478563. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*